Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2008: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Research Abstract |
In order to identify target tumor-related genes for establishing molecular targeting therapy in patients with esophageal squamous-cell carcinoma, we integrated detailed information of genomic/epigenomic alterations in tumors, functional addiction of tumor cells to candidate target genes (oncogene addiction), and clinicopathological significance of altered expression status of those genes. Using this approach, we successfully identified a number of possible novel onocogene and tumor suppressor genes, which may be useful therapeutic as well as diagnostic targets for esophageal cancers.
|